Simran Farms Limited Board Meeting Scheduled for March 30, 2026 to Consider Share Allotment and Postal Ballot Approval

2 min read     Updated on 25 Mar 2026, 02:50 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Simran Farms Limited has officially announced a board meeting scheduled for March 30, 2026, to address key corporate matters including the allotment of 10,18,300 equity shares of Rs. 10/- face value each from warrant conversion and postal ballot approval. The company has filed proper intimation with BSE Limited and will maintain trading window restrictions as per insider trading regulations.

powered bylight_fuzz_icon
35932697

*this image is generated using AI for illustrative purposes only.

Simran Farms Limited has announced that its Board of Directors will convene on March 30, 2026, to deliberate on significant corporate matters including equity share allotment and postal ballot approval. The meeting, scheduled in compliance with Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, will be held at the company's registered office in Indore, Madhya Pradesh.

Official Meeting Notice

The company has filed an official intimation with BSE Limited on March 24, 2026, providing formal notice of the board meeting. The communication, signed by CS Tanu Parmar (Company Secretary & Compliance Officer), confirms the meeting agenda and regulatory compliance requirements.

Meeting Details: Information
Meeting Date: Monday, March 30, 2026
Meeting Venue: Registered Office, Indore (M.P.)
BSE Scrip Code: 519566
ISIN Number: INE354D01017
Filing Reference: SFL/BSE/48/2025-26

Key Agenda Items

The board meeting will address several important business matters that require formal approval and regulatory compliance.

Agenda Item: Details
Share Allotment: 10,18,300 equity shares of face value Rs. 10/- each
Conversion Basis: Warrant conversion upon receipt of balance 75% consideration
Beneficiaries: Promoter group members and other non-promoter persons
Postal Ballot: Notice approval with explanatory statements
Other Matters: Routine business with chair permission

Share Allotment Details

The primary agenda involves the consideration and approval of allotment of 10,18,300 equity shares with a face value of Rs. 10/- each. These shares will be issued pursuant to the conversion of an equal number of share warrants. The allotment is contingent upon the receipt of the balance 75% of the consideration amount from the warrant holders, which include members of the promoter group and other non-promoter persons.

Postal Ballot Authorization

The board will deliberate on the approval of postal ballot notice along with explanatory statements and other required particulars. The board has authorized Company Secretary CS Tanu Parmar to conduct the postal ballot e-voting process, including signing and sending the postal ballot notice along with accompanying documents.

Trading Window Restrictions

In accordance with the company's Code of Conduct for insider trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in company securities will remain closed. The window will reopen 48 hours after the conclusion of the board meeting for all designated persons, their immediate relatives, and connected persons covered under the insider trading regulations.

Corporate Information

Simran Farms Limited operates from its registered office at 1-B, Vikas Rekha Complex, Tower Square, Khatiwala Tank, Indore, Madhya Pradesh. The company has filed the meeting intimation with BSE Limited in both PDF and XBRL formats within the prescribed time limits, maintaining transparency in its corporate communications.

Historical Stock Returns for Simran Farms

1 Day5 Days1 Month6 Months1 Year5 Years
+7.93%0.0%-1.97%-1.36%-13.22%+136.88%

What strategic initiatives or expansion plans might Simran Farms pursue with the additional capital raised from the warrant conversion?

How will the dilution from 10.18 lakh new equity shares impact existing shareholders' ownership and the company's market capitalization?

What specific matters requiring shareholder approval through postal ballot could signal major corporate restructuring or policy changes?

Simran Farms Limited Reports Q3 FY26 Results and Announces Key Board Changes

3 min read     Updated on 16 Feb 2026, 11:27 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Simran Farms Limited announced its Q3 FY26 financial results showing significant quarterly improvement with net profit rising to ₹109.42 lakhs from ₹12.89 lakhs in the previous year. The company also implemented major board changes, appointing Adv. Deepika Sharma as the new Non-Executive Woman Independent Director for a five-year term, while reconstituting all statutory committees following Mrs. Sherry Mac's resignation.

powered bylight_fuzz_icon
32642429

*this image is generated using AI for illustrative purposes only.

Simran Farms Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, alongside significant board changes during a meeting held on February 14, 2026. The company, primarily engaged in poultry breeding and farming activities, reported mixed financial performance with notable improvements in quarterly results.

Financial Performance Overview

The company's standalone financial results show a significant improvement in quarterly performance. For Q3 FY26, Simran Farms reported a net profit of ₹109.42 lakhs compared to ₹12.89 lakhs in the corresponding quarter of the previous year, representing a substantial increase. However, the nine-month performance shows a decline, with net profit at ₹215.30 lakhs compared to ₹904.48 lakhs in the previous year.

Financial Metric: Q3 FY26 Q3 FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations: ₹23,262.48 lakhs ₹18,846.27 lakhs ₹62,603.22 lakhs ₹59,616.95 lakhs
Total Income: ₹23,323.25 lakhs ₹18,909.03 lakhs ₹62,778.38 lakhs ₹59,754.55 lakhs
Net Profit: ₹109.42 lakhs ₹12.89 lakhs ₹215.30 lakhs ₹904.48 lakhs
Basic EPS (₹): 2.89 0.34 5.68 23.85
Diluted EPS (₹): 2.51 0.31 4.83 23.19

Consolidated Results

The consolidated financial results, which include subsidiary Puregene Biotech Limited, show similar trends. Consolidated net profit for Q3 FY26 stood at ₹114.18 lakhs compared to ₹14.09 lakhs in the previous year's quarter. For the nine-month period, consolidated net profit was ₹225.74 lakhs against ₹910.53 lakhs in the corresponding period of the previous year.

Board Changes and New Director Appointment

The board approved significant changes in its composition with Mrs. Sherry Mac (DIN: 10736916) resigning from her position as Non-Executive Woman Independent Director with effect from the close of business hours on February 14, 2026. Based on the recommendation of the Nomination and Remuneration Committee, the board appointed Adv. Deepika Sharma (DIN: 11543076) as Additional Director under the category of Non-Executive Woman Independent Director for a five-year term from February 14, 2026, to February 13, 2031, subject to shareholder approval.

Director Details: Information
Name: Adv. Deepika Sharma
DIN: 11543076
Age: 31 years
Qualification: BA LLB; LLM
Experience: Registered Advocate with M.P. State Bar Council since 2019
Term: 5 years (February 14, 2026 to February 13, 2031)
Other Directorships: None

Committee Reconstitution

Following the board changes, all statutory committees have been reconstituted with the new director. The company has confirmed that Adv. Deepika Sharma has not been debarred from holding the office of Director by virtue of any SEBI order or any other authority.

Committee: Chairperson Members
Audit Committee: Mr. Satinder Pal Singh Bhatia Mr. Gaurav Chhabra, Adv. Deepika Sharma
Nomination and Remuneration Committee: Mr. Satinder Pal Singh Bhatia Mr. Gaurav Chhabra, Adv. Deepika Sharma
Stakeholder Relationship Committee: Mr. Satinder Pal Singh Bhatia Mr. Gaurav Chhabra, Adv. Deepika Sharma

Operational Highlights

The company's revenue from operations increased to ₹23,262.48 lakhs in Q3 FY26 from ₹18,846.27 lakhs in the corresponding quarter of the previous year. Total expenses for the quarter were ₹23,168.36 lakhs, with raw material consumption being the major component at ₹19,595.92 lakhs. The company maintained its focus on poultry breeding and farming activities, with no identifiable operating segments requiring separate disclosure under IND AS-108.

Corporate Compliance

The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors. The results have been reviewed by statutory auditors Khandelwal Kakani & Company in accordance with Regulation 33 of the SEBI Listing Regulations. The company confirmed that all necessary due diligence was exercised to ensure the financial results provide a true and fair view of its affairs. The board meeting commenced at 4:15 PM and concluded at 6:45 PM on February 14, 2026.

Historical Stock Returns for Simran Farms

1 Day5 Days1 Month6 Months1 Year5 Years
+7.93%0.0%-1.97%-1.36%-13.22%+136.88%

More News on Simran Farms

1 Year Returns:-13.22%